Advanced Thyroid Carcinoma: Evolving Systemic Therapy Options
Novel systemic therapy treatment options for patients with advanced thyroid carcinoma continue to be evaluated, including for anaplastic disease, which is almost uniformly lethal. Because some patients with medullary thyroid carcinoma may have indolent and asymptomatic disease, potentially toxic therapy may not be appropriate.
Category
  • Thyroid Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation